Paracelsus SA
0.4 FTEThe score of Paracelsus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +14 % Total assets -25 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Paracelsus's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 24,051 € | ||||
| Equity | 146,406 € | ||||
| Cash | 22,997 € | ||||
| EBITDA | 55,111 € | ||||
| Total assets | 413,042 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Paracelsus's financial analysis
- Solvency35.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Paracelsus
Paracelsus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0469.734.277
- VAT number
- BE0469734277
- Peppol
- Registered · 0208:0469734277 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 17 Jan 2000
- Registered office
- 9310 Aalst
- Size
- Micro · 0.4 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Paracelsus (SA) has been based in Aalst since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 24,051 € and equity of 146,406 €; its revenue is not published. With 0.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.4%, below the median of its sector (44.2%).
Companies similar to Paracelsus
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Lillo Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet 388,983 €
- Pharmacie Derasse Retail sale of pharmaceutical products La Louvière · balance sheet 387,571 €
- Pharmaq Retail sale of pharmaceutical products Mons · balance sheet 375,271 €
- Curapharma Retail sale of pharmaceutical products Zaventem · balance sheet 352,271 €
- I & CM Marbotin Retail sale of pharmaceutical products Schaerbeek · balance sheet 323,588 €
- Farma Booischot Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 558,918 €
- Pharmenform Retail sale of pharmaceutical products Koekelberg · balance sheet 567,837 €
- "Farminco" Retail sale of pharmaceutical products Andenne · balance sheet 589,804 €
Frequently asked questions about Paracelsus
What is the revenue of Paracelsus?
Paracelsus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Paracelsus?
In Belgium, the VAT number is the company number prefixed with BE: BE0469734277 for Paracelsus, if the company is VAT-registered. Its company number (CBE) is 0469.734.277.
Where is the registered office of Paracelsus?
According to the CBE register, the registered office of Paracelsus is in 9310 Aalst.
What is the equity of Paracelsus?
At the close of the 2025 financial year, the equity of Paracelsus amounts to 146,406 €, a solvency of 35.4% of total assets.
How many people work at Paracelsus?
0.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Paracelsus?
The register lists 3 active mandates at Paracelsus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Paracelsus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →